Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
A beginner-friendly sequence to implement Zero Based Budgeting, with actionable steps and easy milestones.
20,040 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
NVIDIA is expanding beyond GPUs into CPU territory, signaling a major strategic shift. This article explains what tha...
A landmark move by the European Commission forces Meta to open WhatsApp to rival AI chatbots. The order could reshape...
New CPI data renews tensions between Trump’s White House and Fed Chair Warsh, signaling a potential policy clash as i...
Trad.Fi and W3 unveil a four-year plan to put a $650 million private-credit pipeline on blockchain rails, aiming to c...
A high-profile SpaceX IPO could unleash a broad wave of capex across aerospace, semiconductors, and industrial suppli...
A 73-year-old retiree with $1.6 million in a traditional 401(K) confronts a sizable first required minimum distributi...
A sharp intraday move put Poet Technologies in the spotlight, but a single day doesn’t tell the full story. This guid...
A quartz countertop tariff could raise renovation costs and ripple through the home-building supply chain, threatenin...
Bitcoin climbs as a tentative Iran peace framework sparks risk-on buying. Japan's ETF market shows steady inflows, wh...
Bitcoin Policy UK rebuked Michael Saylor’s STRC investment promotion as dishonest marketing. The clash highlights gro...
Enbridge approaches its 52-week high as cash flow strengthens and a robust project backlog fuels optimism. Analysts c...